why choose us

First received: March 28, 2026

Clinical Trial: The Role of NaV1.8 in Human Pain Models

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Pain
Acute Pain
Healthy Volunteer Study

Study Type: INTERVENTIONAL


Official Title: The Role of NaV1.8 in Human Pain Models - a Randomized, Placebo-controlled Crossover Microdosing Trial

Brief Summary: This study aims to understand how NaV1.8, a specific type of sodium channel found in peripheral nerves, contributes to different types of pain in humans. To address this, suzetrigine, a highly selective blocker of the NaV1.8 channel, is used. While current pain medications often have side effects that limit their use, NaV1.8 is a promising target for new, non-opioid pain treatments because it is primarily located in the nerves that send pain signals to the brain.This study is a randomised, placebo-controlled…

Read more